The state of Arizona currently has 2 active clinical trials seeking participants for Hepatitis C research studies. These trials are conducted in various cities, including Phoenix, Tucson, Scottsdale and Mesa.
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
Recruiting
This study is being done to determine the effectiveness of using a combination of two different drugs in preventing the transmission of HCV from a HCV positive donor to a HCV negative solid organ recipient.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/11/2024
Locations: Mayo Clinic in Arizona, Phoenix, Arizona
Conditions: Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)
Recruiting
Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. This study will evaluate how safe and effective glecaprevir/pibrentasvir (GLE/PIB) is in adult and adolescent participants with acute HCV infection. GLE/PIB is an approved drug for the treatment of chronic HCV. Around 283 participants at least 12 years of age with acute HCV Infection will be enrolled in approximately 70 sites worldwide. Participants... Read More
Gender:
All
Ages:
12 years and above
Trial Updated:
03/11/2024
Locations: Arizona Health Research /ID# 233558, Chandler, Arizona +1 locations
Conditions: Hepatitis C Virus (HCV)